Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study

Communicating About Chemotherapy-Induced Nausea and Vomiting: A Comparison of Patient and Provider Perspectives

(2017) John M. Salsman et al.   Journal of the National Comprehensive Cancer Network

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

(2012) M. Aapro et al.   ANNALS OF ONCOLOGY

Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy

(2012) Joseph A. Roscoe et al.   JOURNAL OF CLINICAL ONCOLOGY

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2012) Jennifer J. Griggs et al.   JOURNAL OF CLINICAL ONCOLOGY

Supporting Clinical Practice Decisions With Real-Time Patient-Reported Outcomes

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

(2011) Charles S. Cleeland et al.   JOURNAL OF CLINICAL ONCOLOGY

Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized Trial

(2011) Donna L. Berry et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

(2011) Steven Grunberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study

(2011) Doranne L. Hilarius et al.   SUPPORTIVE CARE IN CANCER

Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States

(2011) Chris Craver et al.   JOURNAL OF MEDICAL ECONOMICS

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

(2010) M. Aapro et al.   ANNALS OF ONCOLOGY

Adding The Patient Perspective To Comparative Effectiveness Research

(2010) Albert W. Wu et al.   HEALTH AFFAIRS

Anticipatory nausea and vomiting

(2010) Joseph A. Roscoe et al.   SUPPORTIVE CARE IN CANCER

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

(2010) David G. Warr et al.   SUPPORTIVE CARE IN CANCER

Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists

(2010) Margarita Majem et al.   SUPPORTIVE CARE IN CANCER

Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting

(2010) Thomas A. Burke et al.   SUPPORTIVE CARE IN CANCER

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

(2009) Paul J. Hesketh et al.   SUPPORTIVE CARE IN CANCER

Chemotherapy-Induced Nausea and Vomiting

(2008) Paul J. Hesketh   NEW ENGLAND JOURNAL OF MEDICINE